Ledger.Open graph →
SEC Form D · filed May 4, 2023

Ancilia Biosciences, Inc

Offering
$5.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Dale Pfost · LONDON, United KingdomDirectorRodolphe Barrangou · New York, NYExec · DirectorAlexandra Sakatos · New York, NYExec · DirectorDale Pfost · Broomfield, CODirectorRodolphe Barrangou · Berkeley, CAExec · DirectorAlexandra Sakatos · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗